*BIOLIFE IS SAID TO HAVE DRAWN TAKEOVER INTEREST FROM REPLIGEN

Zymeworks to Acquire Theravance Biopharma, Inc. (not a take-under, this is an existing Strategic Alternatives sit from gap lower $14s, had bad phs3 data)

*COMCAST ANNOUNCES PLANS TO SEPARATE MEDIA & TECHNOLOGY UNITS (yawn)

*Martin Marietta Strikes $13.5B Deal to Combine With Privately Held Lhoist North America, Sources Say — WSJ

*AES STOCKHOLDERS APPROVE ACQUISITION BY GLOBAL INFRASTRUCTURE

*LANTHEUS GETS COMPLETE RESPONSE LETTER FROM FDA (asset-sale strat alt sit)

Integer Holdings Corp: 8-K 2026/06/24 (strat alt sit, Change of Control language)

*NEUPHORIA CONFIRMS IT’S IN TALKS WITH SCANCELL

Stratus Properties Files 8K – Asset Acquisition Or Disposition >STRS (event sit, asset-sale)

*GULFPORT ENERGY TO REPLACE SELECT MEDICAL ON S&P SMALLCAP 600

Diagnostics Firm QuidelOrtho Looks at Testing Unit Sale, Says FT

BT, Verizon to Form $4 Billion International JV to Target Multinational Clients

Google capped Meta’s use of its Gemini AI models because it could not provide enough computing capacity to meet its demand